McNealey Jennifer Isacoff 4

4 · Codex DNA, Inc. · Filed Mar 1, 2022

Form 4

Period: 2022-02-27

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2022-02-27+107,300→ 107,300 total
Exercise: $10.20Exp: 2032-02-27→ Common Stock (107,300 underlying)
Award
Restricted Stock Unit
2022-02-27+28,000→ 28,000 total
→ Common Stock (28,000 underlying)

Footnotes (4)

[F1]The exercise price is the closing price of the Issuer's Common stock on February 28, 2022, the first business day following the date of grant.
[F2]Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 27, 2022
[F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
[F4]Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the remaining RSUs subject to the award shall vest in equal annual installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 27, 2022.

Documents

1 file